By InvitationNot Applicable

Validity and Reliability of the MAP-Hand Scale in Patients With Carpal Tunnel Syndrome

Turkey (Türkiye)180 participantsStarted 2024-12-10

Plain-language summary

The primary aim of the study was to determine the validity and reliability of the "MAP-Hand (Measure of Activity Performance of the Hand)" scale in patients with carpal tunnel syndrome. The secondary aim of the study was to evaluate the hand activity performance in patients with carpal tunnel syndrome.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age 18 and above and able to read and write
✓. Diagnosed with mild or moderate unilateral CTS according to electroneuromyography results at least 6 months ago
✓. Motor-sensory symptoms such as numbness and loss of strength in the hand for at least three months
✓. Volunteers with no history of diabetes, no medical treatment or injections, no surgery, and no cervical radiculopathy or polyneuropathy

Exclusion criteria

✕. Those with trauma, deformity, fracture, muscle contracture and atrophy in the shoulder, forearm and hand
✕. Those who have received corticosteroid injections into the carpal tunnel area within the last three months and have been included in a physiotherapy program
✕. Those who have cognitive problems

What they're measuring

Hand Activity Performance

Timeframe: 24 weeks

Trial details

NCT IDNCT06758193

SponsorKirsehir Ahi Evran Universitesi

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-05-01

View on ClinicalTrials.gov More Carpal Tunnel Syndrome (CTS) trials